H5N1 avian influenza viruses demonstrate different phenotypes, such as pathogenicity after one or serial passages in mammalian hosts or cells. To establish the molecular basis of these phenotypes, we cloned isolates from the lungs of mice infected with human A/Vietnam/1194/ 2004 (H5N1) influenza virus. Large-plaque isolates were less pathogenic to mice than smallplaque isolates. Genome sequencing revealed that the small-plaque and large-plaque isolates differed in several amino acids. In order to assess their effects on pathogenicity in mice, two amino acid changes common to attenuated isolates, one in PB2 (I63T) and the other in PB1 (T677M), were inserted into a wild-type recombinant virus construct. The PB2 (I63T) or PB1 (T677M) mutations alone did not alter the phenotype of H5N1 virus, whereas recombinant virus with both mutations was less pathogenic than the wild-type recombinant virus. Furthermore, the PB1 (T677M) mutation showed a lower replication efficiency, although it had higher polymerase activity. The recombinant virus with the PB2 (63T) mutation replicated as well as the wild-type recombinant virus. These results suggest that the C terminus of PB1 of H5N1 influenza virus mediates virulence attenuation of H5N1 influenza virus in mice, associating with the N terminus of PB2. However, the role of the N terminus of PB2 in virulence attenuation in mice remains unclear.
INTRODUCTION
The first report of H5N1 avian influenza A virus transmission from birds to humans came in 1997 in Hong Kong (CDC, 1997 (CDC, , 1998 . A total of 18 people were infected, and six died. Since 2003, highly pathogenic avian influenza A viruses of H5N1 subtype have occasionally caused fatal disease in humans, with 59 % mortality (WHO, 2011) . Intermittent interspecies transmission to humans or other mammals gives the virus the opportunity to adapt to mammalian hosts and to accumulate the key determinant mutations for human-to-human transmission.
Studies have aimed to discover what type of mutations or adaptations are accumulated by H5N1 virus after its transmission to mammalian hosts. Mase et al. (2006) found that A/chicken/Yamaguchi/7/2004(H5N1) isolated from mouse brain rapidly increased in virulence to mice after a single passage in mice. It has also been reported from studies in vitro that a mixed PB2 population is present in the original H5N1 specimens and that, during propagation in Madin-Darby canine kidney (MDCK) cells or embryonated chicken eggs, PB2 with Lys at position 627 and Asp at position 701, which shows higher pathogenicity and replication efficiency, was preferentially selected and accumulated (Le et al., 2009 ).
Virulence of H5N1 virus in mammals is thought to be polygenic (Chen et al., 2007; Govorkova et al., 2005) at the molecular level. By reverse genetics and reassortment studies, several viral genes and gene products have been identified as possibly responsible for the high pathogenicity of H5N1 influenza viruses (Bender et al., 1999; Bornholdt & Prasad, 2008; Bright et al., 2003; Chen et al., 2004 Chen et al., , 2007 de Jong et al., 2006; Hatta et al., 2001; Jackson et al., 2008; Jiao et al., 2008; Katz et al., 2000; Le et al., 2009; Lee et al., 2007; Long et al., 2008; Matrosovich et al., 1999; Min et al., 2007; Seo et al., 2002; Steel et al., 2009; Subbarao & Shaw, 2000) , such as multiple residues at the cleavage site of HA that increase virulence (Hatta et al., 2001; Horimoto & Kawaoka, 1994) , the E627K mutation in PB2, which is important for replication in mammalian cells (Subbarao et al., 1993) , serine at position 66 of PB1-F2, which increases virulence (Conenello et al., 2007) , and D92E in NS1, which increases resistance to tumour necrosis factor alpha and gamma interferon host responses for H5N1 virus (Seo et al., 2002) . However, given the high rate of mutation and reassortment of H5N1 influenza viruses (Chen & Holmes, 2006; Guan et al., 2004 Guan et al., , 2002 Smith et al., 2006; Vijaykrishna et al., 2008) and the polygenic nature of their virulence in mammals, it is difficult to draw general conclusions about virulence factors of the virus. Several viruses isolated from fatal human cases lack the E627K substitution Guan et al., 2004; Li et al., 2004; Shinya et al., 2005; Steel et al., 2009) . Moreover, the effects on polymerase activity and in vitro replication efficiency are virus-and cell type-specific, and do not mediate changes in viral lung load in animals (McAuley et al., 2010) . Therefore, it seems that an association between two or more fragments or sites is necessary to mediate the high pathogenicity of H5N1 influenza virus.
In this study, we aimed to clarify what type of mutation or selection by mice occurred after a single passage of an H5N1 virus in mice, and to look for associations between mutations and the pathogenicity of the virus. Therefore, we determined the pathogenicity of selected variants by plaque-purification from the lungs of mice infected with A/Vietnam/1194/2004(H5N1) (VN1194). We then analysed the genome sequences of selected variants with varying pathogenicity and validated the determinant mutations responsible for changes in virus pathogenicity by reverse genetics.
RESULTS

Selection of virulence variants from the lungs of mice infected with VN1194
The plaque-forming ability of VN1194 and its mouse-lung variants was determined in MDCK cells. Fig. 1 shows that VN1194 formed homogeneously small and punctiform plaques, while VN1194-ML formed a few larger plaques, amongst a majority of smaller plaques. Two larger-plaque variants and two smaller-plaque variants obtained from VN1194-ML by plaque-purification were selected. Our data showed that there was a difference in plaque-forming capacity between the larger-plaque and smaller-plaque isolates (Fig. 1) . Subsequently, the pathogenicity of these two variants and wild VN1194 in mice was determined. Table 1 and Fig. 2 show that VN1194-MLL1 and VN1194-MLL4 were less pathogenic than VN1194-MLS2, VN1194-MLS3 and VN1194 in mice, at an intranasal inoculation of 10 p.f.u.
Sequence variations between the wild-type and plaque-purified VN1194 viruses Genome sequencing of wild-type and plaque-purified VN1194 viruses was carried out to investigate what genetic changes might be responsible for the differences in pathogenicity. All eight genes of the plaque-purified variants and VN1194 were amplified by RT-PCR and ligated into plasmid pHW2000. Nucleotide changes in the isolated variants are shown in Supplementary AIle) in PA. The same substitutions were also found in the four plaquepurified variants in this study. Compared with the wildtype virus sequence, there were four amino acid changes in VN1194-MLS2 (three in PB2 and one in NS1), VN1194-MLL1 (three in PB2 and one in PB1) and VN1194-MLL4 (one in PB2, one in PB1 and two in HA1) and two altered amino acids in VN1194-MLS3 (one in PB2 and one in PA). Moreover, there were two common substitutions in PB2 (Ile 63 AThr) and PB1 (Thr 677 AMet) of VN1194-MLL1 and VN1194-MLL4 compared with VN1194-MLS2, Fig. 1 . Plaque formation assay of VN1194 and VN1194-ML and variants VN1194-MLL1, VN1194-MLL4, VN1194-MLS2 and VN1194-MLS3 isolated from VN1194. Confluent monolayers of MDCK cells were inoculated with 10-fold serial dilutions of H5N1 virus, overlaid with 1 % hypo-Tm-solved agarose and maintained at 35 6C. Two days after inoculation, cells were stained with neutral red and plaque morphology was evaluated. Larger plaques were differentiated from smaller plaques when their size was twice that of smaller ones.
VN1194-MLS3 and VN1194. The association of these two amino acid changes with the change in pathogenicity was examined in this study.
Generation of recombinant viruses by a reversegenetic method
In order to determine whether the common amino acid changes in the VN1194-MLL1 and VN1194-MLL4 viruses contributed to reduced pathogenicity in mice, reversegenetic plasmid pHW2000 was used to rescue four viruses with or without the two amino acid changes and to determine their pathogenicity. In the present study, an eight-plasmid set was used that encoded each gene of A/ Vietnam/1194/2004, with two more plasmids that encoded PB2 with the 63T mutation and PB1 with the 677M mutation. The mutated sites in PB2 and PB1 or both in fragments of rVN1194-PB2 63T , rVN1194-PB1 677M and rVN1194M were confirmed by whole-genome sequencing, and there were no genomic mutations in fragments PA, HA, NP, NA, M and NS in the four recombinant viruses. Plaque assays showed that all four recombinant viruses formed small plaques, like those formed by wild-type VN1194 ( Supplementary Fig. S1 ). Groups of ten 6-to 8-week-old, 15-17 g female mice were infected intranasally with 10 p.f.u.; dead mice in each group were counted daily for 14 days.
Pathogenicity of the recombinant viruses
Differences in pathogenicity between the four recombinant viruses (rVN1194, rVN1194M, rVN1194-PB2 63T and rVN1194-PB1 677M ) are shown in Fig. 3 and Table 2 . At a virus dose of 10 p.f.u., mortality was 100 % in mice inoculated with rVN1194 (10/10) and with rVN1194-PB2 63T (10/10) and 90 % in mice inoculated with rVN1194-PB1 677M (9/10). However, only two mice inoculated with rVN1194M died (2/10) ( Fig. 3a-d) . Furthermore, Fig. 3 (e) shows that virus rVN1194M caused less weight loss in mice than did rVN1194, rVN1194-PB2 63T and rVN1194-PB1 677M . The mean survival time (t-test, P,0.01) and MLD 50 (50 % mouse lethal dose) also showed that rVN1194M was less pathogenic in mice than rVN1194, rVN1194-PB2 63T and rVN1194-PB1 677M . Though the MLD 50 of rVN1194-PB2 63T and rVN1194-PB1 677M was a little higher than that of rVN1194 (Table 2) , there was no significant difference in mouse body weight change, mortality rate or mean survival time (t-test, P.0.05) among mice infected with rVN1194, rVN1194-PB2 63T and rVN1194-PB1 677M .
Growth of recombinant viruses in human and mouse cells Fig. 4 (a) shows that both rVN1194 and rVN1194-PB2 63T grew to high titres (approx. 10 7 p.f.u. ml 21 ), with no notable difference in titre (t-test, P.0.05), in Neuro 2A cells, while both rVN1194M and rVN1194-PB1 677M grew to only approx. 10 5.5 p.f.u. ml 21 in this cell type, again without a significant difference in titre (t-test, P.0.05). There was a significant difference in virus titres at 72 h post-inoculation (p.i.) between the virus pairs rVN1194 and rVN1194-PB2 63T on the one hand and rVN1194M and rVN1194-PB1 677M on the other (t-test, P,0.05). This result was consistent with the presence of the T677M substitution in PB1 of rVN1194M and rVN1194-PB1 677M . Also, both rVN1194 and rVN1194-PB2 63T grew to higher titres (approx. 10 4 p.f.u. ml
21
) than rVN1194M and rVN1194-PB1 677M (approx. 10 3 p.f.u. ml 21 ) in human epithelial lung cells (A549) (Fig. 4b) and mouse macrophage cells (RAW264.7) (Fig. 4c) , showing statistically significant differences between viruses with or without the T677M substitution in PB1 (t-test, P,0.05) at 72 or 48 h p.i. These data showed that the T to M mutation in 677 of PB1 results in lower virus growth in these mammalian cell lines.
Polymerase activities of reconstituted ribonucleoprotein complexes
To investigate whether the mutations in PB2 and PB1 changed the enzymic activity of the RNA-dependent RNA (d) . Groups of ten 6-to 8-week-old, 15-17 g female mice were infected intranasally with 10 p.f.u.; dead mice in each group were counted daily for 14 days. Mean survival time was estimated by the KaplanMeier method. Fisher's exact test was used to analyse differences between groups in survival rates when no omitted observations were present. Mean survival time in the rVN1194M group was significantly different from that of the other three groups (P,0.01), but there was no significant difference between any other two groups (P.0.05). (e) Changes in mouse body weight expressed as percentage change.
polymerase, we analysed the reconstituted ribonucleoprotein complexes, composed of PB2, PB1, PA and NP, in 293T cells by a luciferase minigene assay. The levels of PB1 and PB2 expression in each group were identical ( Supplementary Fig. S2 ). The polymerase activity of rVN1194M, carrying PB1-677M and PB2-63T, was 63-fold higher than that of rVN1194 (Fig. 4d, bars 1 and 2 ). To enable us to assign the increase in polymerase activity to a single mutation, two ribonucleoprotein complexes were investigated separately carrying PB2-63T and PB1-677M. The polymerase activity of rVN1194M PB1 was 130-fold higher, while that of rVN1194M PB2 was 90 % of that of rVN1194 PB2 (Fig. 4d, bars 3 and 4) . Taken together, the mutations in rVN1194M enhanced the polymerase activity in mammalian cells considerably, with a significant upregulation resulting from the mutation in PB1 (677M) (t-test, P,0.01) and a small downregulation resulting from the mutation in PB2 (63T) (t-test, P.0.05). Polymerase complexes marked with an asterisk had a statistically higher luciferase activity than the wild-type VN1194 polymerase complex (analysis of variance; t-test, P,0.01).
Difference in tissue tropism between rVN1194 and rVN1194M in mice
Signs of severe damage to the central nervous system (CNS), including hemiplegia, ataxia, etc., were observed in more than 50 % of mice inoculated with VN1194, VN1194-MLS2 or VN1194-MLS3, but not in mice inoculated with VN1194-MLL1 or VN1194-MLL4. Therefore, we hypothesized that there might be differences in neurotropism or neurovirulence between lethal and less-pathogenic viruses in this study. To determine the tropism of these viruses in mice, four groups of mice were inoculated intranasally with 10 p.f.u. of rVN1194, rVN1194M, rVN1194-PB1 677M or rVN1194-PB2 63T . Virus titres in mouse lungs and brains were determined by TCID 50 . Fig. 5 shows that there were detectable titres in all lung samples. On day 3 p.i., virus titres in lung samples of mice inoculated with rVN1194M or rVN1194-PB1 677M (no significant difference between the two groups; t-test, P.0.05) were notably lower (t-test, P,0.05) than those of mice inoculated with rVN1194 or rVN1194-PB2 63T (also no significant difference between the two groups; t-test, P.0.05). On day 6 p.i., lung samples from rVN1194M-inoculated mice had the lowest titres, and there was no significant difference in virus titre in lung samples from the other three groups. The difference in virus titre in lung samples on day 6 p.i. between the attenuated rVN1194M and the other viruses suggested that the differences in pathogenicity at least partly reflected differences in viral replication in the lung. No virus was detected by TCID 50 in brains of rVN1194M-inoculated mice on day 3 or 6 p.i., while the virus titres in 2/3 mice infected with rVN1194 or rVN1194-PB2 63T were as much as 4 log 10 TCID 50 (g tissue)
21
. Interestingly, we did not detect virus in rVN1194-PB1 677M -inoculated mice, though the virus had pathogenicity similar to that of rVN1194 and rVN1194-PB2 63T .
DISCUSSION
In this study, it was shown that VN1194, isolated from a fatal human influenza case in Vietnam, formed homogeneous small plaques in MDCK cells and was highly pathogenic in mice. After a single passage in mice, mixed plaques of different sizes developed in the mouse lung. Larger and smaller plaque-purified viruses isolated from the mouse lung differed in pathogenicity and genome sequence. Comparison of survival rate, mean survival time and MLD 50 in mice revealed that the two larger-plaque variants (VN1194-MLL1 and VN1194-MLL4) were attenuated in virulence in mice, being less pathogenic than VN1194-MLS2, VN1194-MLS3 and VN1194. Moreover, genome sequencing revealed several amino acid exchanges in the polymerase, HA and NS1 of the larger and smaller variants, including a common I63T exchange in PB2 and another common T677M exchange in PB1.
We next investigated whether the two common exchange sites contributed to the attenuation of the larger-plaque lung variants using a reverse-genetic method. The recombinant virus rVN1194 behaved essentially like the wild VN1194, with a similar high virus titre in chicken embryos and almost the same pathogenicity in mice (Tables 1  and 2 ). The pathogenicity in mice of the other three recombinant viruses, rVN1194M, rVN1194-PB2 63T and rVN1194-PB1 677M , was also determined. rVN1194M was significantly less pathogenic than rVN1194, while the pathogenicity of rVN1194-PB2 63T and rVN1194-PB1 677M was almost as high as that of rVN1194. Therefore, the mutations I63T in PB2 and T677M in PB1 co-mediated the reduced pathogenicity of rVN1194M. The polymerase appeared to contain important determinants of pathogenicity, as has been shown previously (Gabriel et al., 2005; Govorkova et al., 2005; Hatta et al., 2001; Naffakh et al., 2000; Salomon et al., 2006; Shinya et al., 2004) .
The RNA-dependent RNA polymerase of influenza virus is composed of three viral polymerase proteins (PB1, PB2 and PA) and is involved in both transcription and replication of the RNA genome. The PB1 subunit plays key roles both in catalytic functions of RNA polymerization (Honda et al., 2002) , as a transcriptase through binding PB2, and as a replicase by interacting with PA (Honda et al., 2002) or virus-generated small RNAs (Perez et al., 
2010
). Previous studies have shown that the C terminus of PB1 bonded PB2 efficiently and folded into a three-helical bundle structure, any deletion of which eliminated transcriptional function (Poole et al., 2007 ). An X-ray structure of an 86 aa C-terminal fragment of PB1 with a 37 aa N-terminal peptide from PB2 showed that they interact tightly to form a conserved a-helical region (Sugiyama et al., 2009 ). The two mutations in PB2 and PB1 located in or around the binding area of the two proteins increased the polymerase activity of rVN1194M, as indicated by the minigene luciferase results (Fig. 4) . However, the increased polymerase activity did not result in higher replication efficiency or pathogenicity. Therefore, an excess of polymerase activity appeared to result in lower replication efficiency, indicating that an optimum polymerase activity is required for virus transcription and replication. Moreover, the reduced replication efficiency of rVN1194M might be responsible for its attenuated pathogenicity. Interestingly, RAW264.7 cells inoculated with rVN1194M were completely dead at 72 h, unlike the other cells. This suggests that rVN1194M was more virulent towards mouse macrophage cells, which play an important role in the pathogenicity of H5N1 virus (Lee et al., 2009; Mok et al., 2007) .
Previous studies have suggested that viral replication is correlated with negative disease outcome in fatal cases with the highest viral loads . After various interventional therapies aimed at limiting tissue injury and viral replication, it has been shown that the virus is not confined to the lung, and is able to disseminate beyond the respiratory tract (Gu et al., 2007; Uiprasertkul et al., 2005 Uiprasertkul et al., , 2007 . Animal studies have provided important supplementary information about the natural course of H5N1 influenza. The majority of these animal studies have indicated tissue injury in extra-pulmonary organs, in particular in the brain (Govorkova et al., 2005; Maines et al., 2005; Nishimura et al., 2000; Rimmelzwaan et al., 2001 Rimmelzwaan et al., , 2006 Yen et al., 2007; Zitzow et al., 2002) . The presence of the lowest observed titre in the lungs of mice infected with rVN1194M on both day 3 and 6 p.i. reflected the lowest replication efficiency of this virus in vivo, indicating that the attenuated pathogenicity of rVN1194M was correlated with its lower replication in the lung. Furthermore, virus could be detected by TCID 50 in brain samples from mice inoculated with rVN1194 or rVN1194-PB2 63T , but not in brain samples of mice inoculated with rVN1194M, suggesting reduced dissemination of the attenuated virus in mice. Interestingly, rVN1194-PB1 677M also could not reach the mouse CNS, though it was as pathogenic as rVN1194 and rVN1194-PB2 63T . It seems that the T677M mutation in PB1 is associated with dissemination of the virus in mice.
Taking together, the T677M exchange in PB1 decreased virus replication efficiency in vitro, though it increased polymerase activity dramatically, and interacted with the I63T exchange in PB2 to decrease virus replication efficiency in the mouse lung and virus dissemination to the CNS in mice. These two exchanges, in PB1 and PB2, therefore mediated the attenuated pathogenicity of rVN1194M.
Our present study provides an insight into intersegment (PB2 and PB1) interaction in mediating pathogenicity attenuation, which has been postulated by a statistical model (Bayesian graphical model; Lycett et al., 2009) . However, several questions remain. One unresolved question is that the T677M exchange in PB1 alone resulted in decreased virus replication efficiency in vitro but not in vivo. Another, more important question is that the I63T exchange in PB2 did not result in significant changes in polymerase activity, replication efficiency in vitro or in vivo pathogenicity of rVN1194-PB2 63T , but it could interact with the T677M exchange in PB1 to attenuate the pathogenicity of rVN1194M. Our data suggest a novel virulence mechanism involving the combination of PB2 and PB1. Another outstanding question concerns the roles of other amino acid exchanges in VN1194-MLL1 and VN1194-MLL4 in changes in virus pathogenicity, replication efficiency and plaque formation. Plaque formation by the four recombinant viruses was determined, and they all formed only homogeneously small, punctiform plaques ( Supplementary Fig. S1 ), suggesting that the T677M exchange in PB1 and the I63T exchange in PB2 did not contribute to the change in plaque formation of VN1194. (VN1194) was propagated twice for 48 h in 11-day-old chicken embryos. Two larger-plaque variants (VN1194-MLL1 and VN1194-MLL4) and two smaller-plaque variants (VN1194-MLS2 and VN1194-MLS3) were selected separately by plaque-purification from the large plaques and smaller plaques formed by a mouse lung variant (VN1194-ML). VN1194-ML was isolated on day 3 p.i. from the lung of a mouse that was inoculated intranasally with 10 4 p.f.u. VN1194. The entire lung was removed and homogenized in sterile PBS and the homogenate was then used for plaque assay and plaque isolation. VN1194-MLL1, VN1194-MLL4, VN1194-MLS2 and VN1194-MLS3 were propagated once for 48 h in 11-day-old embryonated chicken eggs. All H5N1 viruses were handled under biosafety level 3 conditions. Plasmids. In order to clone all eight genes of VN1194 and the purified variants, each segment was amplified by RT-PCR from isolated RNA (using Pfu polymerase; Promega) and ligated into plasmid pHW2000 (Hoffmann et al., 2000) for virus rescue and polymerase activity assay. For the polymerase activity reporter assay, the influenza minigene set (PB2, PB1, PA and NP) was used with the reporter plasmid pPolI-NPluc. The reporter plasmid expresses a negative-sense RNA transcript carrying the complete ORF of the firefly luciferase gene (GenBank accession no. AF053462) flanked by non-coding regions of the NP segment of VN1194 virus (23 nt of the viral RNA 59 end and 45 nt of the 39 end; GenBank accession no. AAT70629). manufacturer's instructions. The medium was replaced with DMEM containing 2 % FBS at 6 h post-transfection and the supernatant was collected after 48 h. The stock virus was propagated in 11-day-old embryonated chicken eggs after another 48 h. In order to identify possible mutations in the recombinant viruses, each viral gene segment of all recombinant viruses was amplified by RT-PCR and sequenced. Recombinant viruses were named rVN1194 (recombinant virus with eight segments from wild-type VN1194), rVN1194-PB2 63T , rVN1194-PB1 677M and rVN1194M (recombinant viruses with PB2-63T, PB1-677M or both).
Growth curves. A549, RAW264.7 and Neuro-2A cells were inoculated with H5N1 virus at an m.o.i. of 0.01 and maintained in DMEM containing 2 % FBS at 35 uC. At 24, 48 and 72 h p.i., supernatants were collected and growth was determined by plaque titration on MDCK cells. Growth curves were determined in three independent experiments.
Polymerase activity assay after transfection. Briefly, 293T cells were transfected with pHW2000 plasmid constructs encoding PB2 63I or PB2 63T , PB1 677T or PB1 677M , PA, NP and pPol1-NP-Luc (1 mg each) with Lipofectamine 2000 according to the manufacturer's instructions. The medium was replaced with DMEM containing 10 % FBS at 6 h post-transfection. At 24 h post-transfection, cells were harvested for analysis. Expression of PB2 and PB1 in each group was quantified by real-time quantitative PCR to guarantee the same level of expression of the two forms of PB2 or PB1 in the polymerase activity assay (Supplementary Fig. S2 ). Subsequently, luciferase activity was determined by using a Promega luciferase assay system. Experiments were done in triplicate, and means were determined.
Animal experiments. Animal experiments were performed according to the guidelines of Chinese Animal Protection law. All animal protocols were approved by the relevant Chinese authorities. Female BALB/c mice (Beijing Experimental Animal Center) weighting 14-17 g at 4-6 weeks of age were anaesthetized with 100 ml 1 % napental by intraperitoneal injection and were then inoculated intranasally with 50 ml infectious virus diluted in PBS. In order to determine the MLD 50 (50 % mouse lethal dose), four mice were inoculated intranasally with serial 10-fold dilutions of virus. MLD 50 titres were calculated by the method of Reed & Muench (1938) and expressed as p.f.u. Four groups of mice were inoculated intranasally with H5N1 viruses at a dose of 10 p.f.u.; 10 mice in each group were monitored for changes in body weight and mean survival time, and three in each group were sacrificed on day 3 and 6 p.i. for determination of virus tropism in mice. The entire lung or brain was removed and homogenized in 1 ml sterile PBS; 50 % tissue culture infective dose (TCID 50 ml 21 ) titres were calculated by the method of Reed & Muench (1938) .
